Kiniksa Pharmaceuticals

KNSA

Market cap $2.88B

Buy

Hold

Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$51

31% upside

High target

positive

0 neutral

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Wedbush David Nierengarten 100% 1-yr KNSA win rate				13 Oct ‘25 2 days ago
TD Cowen Nicholas Lorusso 100% 1-yr KNSA win rate				29 Sep ‘25 16 days ago
Wells Fargo Eva Fortea Verdejo 100% 1-yr KNSA win rate				25 Sep ‘25 20 days ago
Jefferies Roger Song 100% 1-yr KNSA win rate				29 Jul ‘25 2 months ago